Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Somali Terrorist Behind Canada Attack Entered U.S. From Mexico, Obama DHS Let Him Go
Progress: "Artist" Who Breastfed Dog, Fertilized Her Own Egg With Dog Cell Wins Prestigious Prize
Anti-Establishment, Trump-Like Billionaire Wins Czech Election
Jimmy Carter On Clinton Foundation: 'Rosie And I Put Money In The Carter Center, We Never Take Any Out'
U. Of Penn Teaching Aide: I "Always" Call On Black Female Students First, White Men Last
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.